BRIEF-Celadon Pharmaceuticals Says It Has Not Received Funds Under £1.95M Utilisation Request

Reuters03-19

March 19 (Reuters) - Celadon Pharmaceuticals PLC CEL.L:

CELADON PHARMACEUTICALS : CONFIRM THAT CO HAS NOT RECEIVED FUNDS REQUESTED BY CO UNDER ITS £1.95M UTILISATION REQUEST
CELADON PHARMACEUTICALS : BOARD HAS RESOLVED TO INSTRUCT CO TO DRAWDOWN A FURTHER £2M FROM ITS COMMITTED CREDIT FACILITY

Source text: ID:nRSS2035Ba

Further company coverage: CEL.L

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2520947337?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-19 15:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2520947337","market":"us","top_or_hot":-1,"title":"BRIEF-Celadon Pharmaceuticals Says It Has Not Received Funds Under £1.95M Utilisation Request","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Celadon Pharmaceuticals Says It Has Not Received Funds Under £1.95M Utilisation Request</title></head><body><p><span>March 19 (Reuters)</span><span> - </span>Celadon Pharmaceuticals <a href=\"https://laohu8.com/S/PLC\">PLC</a> <span>CEL.L</span>:</p><ul><li><p>CELADON PHARMACEUTICALS : CONFIRM THAT CO HAS NOT RECEIVED FUNDS REQUESTED BY CO UNDER ITS £1.95M UTILISATION REQUEST</p></li><li><p>CELADON PHARMACEUTICALS : BOARD HAS RESOLVED TO INSTRUCT CO TO DRAWDOWN A FURTHER £2M FROM ITS COMMITTED CREDIT FACILITY</p></li></ul><p>Source text: <span>ID:nRSS2035Ba</span></p><p>Further company coverage: <span>CEL.L</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Celadon Pharmaceuticals Says It Has Not Received Funds Under £1.95M Utilisation Request</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Celadon Pharmaceuticals Says It Has Not Received Funds Under £1.95M Utilisation Request\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-03-19 15:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Celadon Pharmaceuticals Says It Has Not Received Funds Under £1.95M Utilisation Request</title></head><body><p><span>March 19 (Reuters)</span><span> - </span>Celadon Pharmaceuticals <a href=\"https://laohu8.com/S/PLC\">PLC</a> <span>CEL.L</span>:</p><ul><li><p>CELADON PHARMACEUTICALS : CONFIRM THAT CO HAS NOT RECEIVED FUNDS REQUESTED BY CO UNDER ITS £1.95M UTILISATION REQUEST</p></li><li><p>CELADON PHARMACEUTICALS : BOARD HAS RESOLVED TO INSTRUCT CO TO DRAWDOWN A FURTHER £2M FROM ITS COMMITTED CREDIT FACILITY</p></li></ul><p>Source text: <span>ID:nRSS2035Ba</span></p><p>Further company coverage: <span>CEL.L</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CEL.UK","symbol_name":"CELADON PHARMACEUTICALS PLC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20B9:1","article_id":"2520947337","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2520947337","pubTimestamp":1742369618,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Celadon Pharmaceuticals Says It Has Not Received Funds Under 1.95M Utilisation RequestMarch 19 (Reuters) - Celadon Pharmaceuticals PLC CEL.L:CELADON PHARMACEUTICALS : CONFIRM THAT CO HAS NOT REC","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CEL.UK":"CELADON PHARMACEUTICALS PLC","BK5011":"制药"},"translate_title":"简介-Celadon Pharmaceuticals表示尚未收到195万英镑使用请求下的资金","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CEL.UK":0.9},"content_text":"BRIEF-Celadon Pharmaceuticals Says It Has Not Received Funds Under £1.95M Utilisation RequestMarch 19 (Reuters) - Celadon Pharmaceuticals PLC CEL.L:CELADON PHARMACEUTICALS : CONFIRM THAT CO HAS NOT RECEIVED FUNDS REQUESTED BY CO UNDER ITS £1.95M UTILISATION REQUESTCELADON PHARMACEUTICALS : BOARD HAS RESOLVED TO INSTRUCT CO TO DRAWDOWN A FURTHER £2M FROM ITS COMMITTED CREDIT FACILITYSource text: ID:nRSS2035BaFurther company coverage: CEL.L ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2520947337","isCrawlerRequest":true}